Jeffrey D. Capello's Insider Trades & SAST Disclosures
Jeffrey D. Capello's most recent trade in Neogen Corp. was a trade of 20,712 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on April 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey D. Capello.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogen Corp. | Jeffrey D. Capello | Director | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 22 Apr 2025 | 20,712 | 26,629 (0%) | 0% | 4.8 | 100,217 | Common Stock |
| Neogen Corp. | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.81 per share. | 28 Oct 2024 | 1,776 | 5,917 (0%) | 0% | 13.8 | 24,527 | Common Stock |
| Neogen Corp. | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 1,776 | 3,552 | - | - | Restricted Stock Units | |
| Neogen Corp. | Jeffrey D. Capello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 18,653 | 18,653 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jeffrey D. Capello | Director | Grant, award, or other acquisition of securities at price $ 13.58 per share. | 24 Oct 2024 | 6,075 | 15,840 | - | 13.6 | 82,499 | Restricted Stock Units |
| Neogen Corp. | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 2,070 | 2,071 | - | - | Restricted Stock Units | |
| Neogen Corp. | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.07 per share. | 07 Oct 2024 | 2,070 | 4,141 (0%) | 0% | 15.1 | 31,195 | Common Stock |
| Agios Pharmaceuticals Inc | Jeffrey D. Capello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 11,774 | 11,774 | - | - | Stock options (right to buy) | |
| Agios Pharmaceuticals Inc | Jeffrey D. Capello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,120 | 2,120 | - | - | Restricted stock units | |
| Agios Pharmaceuticals Inc | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 1,976 | 1,976 (0%) | 0% | 0 | Common stock | |
| Agios Pharmaceuticals Inc | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 1,976 | 3,953 | - | - | Restricted stock units | |
| Agios Pharmaceuticals Inc | Jeffrey D. Capello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 33,177 | 33,177 | - | - | Stock options (right to buy) | |
| Agios Pharmaceuticals Inc | Jeffrey D. Capello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 5,929 | 5,929 | - | - | Restricted stock units | |
| Neogen Corp. | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 18,416 | 18,416 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jeffrey D. Capello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 6,212 | 6,212 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges